New York Based Pfizer Inc Shares Crashes

New York-based Pfizer Inc. shares slipped 0.07% to $41.02 Wednesday. This proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.82% to 4,358.69 and the Dow Jones Industrial Average DJIA rising 0.83% to 34,798.00.

Pfizer Inc. closed $2.06 short of its 52-week high ($43.08), which the company reached on December 9th. The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ rose 0.62% to $169.49, Merck & Co. Inc. MRK rose 0.29% to $76.39, and Novartis AG ADR NVS rose 0.27% to $90.48.

Trading volume (27.5 M) eclipsed its 50-day average volume of 22.0 M. New York Pfizer Inc closed the most recent trading day at $40.15, moving -0.5% from the previous trading session. This change was narrower than the S&P 500’s 1.59% loss on the day. Coming into today, shares of the drugmaker had gained 3.97% in the past month. In that same time, the Medical sector lost 4.1%, while the S&P 500 gained 2.53%.

Wall Street will be looking for positivity from PFE as it approaches its next earnings report date. This is expected to be July 28, 2021. In that report, analysts expect PFE to post earnings of $0.96 per share. This would mark year-over-year growth of 23.08%. Meanwhile, our latest consensus estimate is calling for revenue of $17.54 billion, up 48.61% from the prior year quarter.